CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $735,889
- in 3 filings
Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-02 | Colao Massimilano Chief Commercial Officer | Grant or award · Restricted Stock Unit | +104,080 | 104,080 | ||
| 2022-03-02 | Colao Massimilano Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +178,063 | 178,063 | ||
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award | +28,300 | 42,035 | ||
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Sale | −9,068 | $12.01 | $109K | 32,967 |
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award · Restricted Stock Unit | +312,240 | 312,240 | ||
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award · Stock Option (right to buy) | +534,188 | 534,188 | ||
| 2022-03-02 | Robertson Stephen P. EVP, General Counsel | Grant or award | +8,500 | 11,682 | ||
| 2022-03-02 | Robertson Stephen P. EVP, General Counsel | Grant or award · Restricted Stock Unit | +104,080 | 104,080 | ||
| 2022-03-02 | Robertson Stephen P. EVP, General Counsel | Grant or award · Stock Option (right to buy) | +178,063 | 178,063 | ||
| 2022-03-02 | Solomons Neil Chief Medical Officer | Grant or award | +8,500 | 95,799 | ||
| 2022-03-02 | Solomons Neil Chief Medical Officer | Sale | −4,846 | $12.01 | $58K | 90,953 |
| 2022-03-02 | Solomons Neil Chief Medical Officer | Grant or award · Restricted Stock Unit | +72,856 | 72,856 | ||
| 2022-03-02 | Solomons Neil Chief Medical Officer | Grant or award · Stock Option (right to buy) | +124,644 | 124,644 | ||
| 2022-03-02 | Huizinga Robert Bindert EVP of Research | Grant or award | +8,500 | 74,228 | ||
| 2022-03-02 | Huizinga Robert Bindert EVP of Research | Sale | −4,849 | $12.01 | $58K | 69,379 |
| 2022-03-02 | Huizinga Robert Bindert EVP of Research | Grant or award · Restricted Stock Unit | +62,448 | 62,448 | ||
| 2022-03-02 | Huizinga Robert Bindert EVP of Research | Grant or award · Stock Option (right to buy) | +106,838 | 106,838 | ||
| 2022-01-03 | Hagan Joseph P Director | Option exercise | +40,000 | $5.08 | $203K | 43,500 |
| 2022-01-03 | Hagan Joseph P Director | Sale | −39,366 | $22.58 | $889K | 4,134 |
| 2022-01-03 | Hagan Joseph P Director | Sale | −634 | $23.29 | $15K | 3,500 |
Page 12 of 18 · 345 trades